Abstract
The purpose of this study was to examine the efficacy of selective laser trabeculoplasty (SLT) in eyes with early and more advanced stages of open angle glaucoma within 1 year of follow-up. Retrospective chart review in a consecutive series of patients treated by SLT to reduce intraocular pressure (IOP) or decrease number of topical medications in cases of discomfort and allergy. The cup-to-disc ratio of the optic nerve and the GSS 2 (glaucoma staging system 2) was used to differentiate between early (group 1) and more advanced (group 2) stages of glaucoma. At the time of SLT treatment, no new signs of glaucoma progression were seen. Only the first treated eye of every patient was included in the analysis. In group 1 (early glaucoma), 27 eyes were included. IOP reduction <21 mmHg/>20 % of the preoperative IOP-value and reduction of medication were achieved in 17 eyes (62.96 %). Successful re-treatment was necessary in 2 eyes (7.4 %). In group 2 (advanced glaucoma), 44 eyes underwent SLT. In eight eyes (18.18 %), filtrating surgery was necessary after initial SLT. In the remaining 36 eyes, IOP reduction <21 mmHg/>20 % of the baseline IOP was achieved in 26 eyes (59.09 % of 44 eyes) and IOP reduction <18 mmHg/> 30 % of the baseline IOP in 22 eyes (50 % of 44 eyes). SLT was safe and effective in nearly 2/3 of early glaucoma patients and also in 50 % of advanced glaucoma patients using stronger criteria of success. Failure of SLT in advanced glaucoma should lead to immediate filtrating surgery, which seems not to be associated with higher risk of fibrosis.
Similar content being viewed by others
References
Wise JB, Witter SC (1979) Argon laser therapy for open-angle glaucoma, a pilot study. Arch Ophthalmol 97:319–322
Barkana Y, Belkin Y (2007) Selective laser trabeculoplasty. Surv Ophthalmol 52:634–654
Schwartz AL, Van Veldhuisen PC, Gaasterland DE, Ederer F, Sullivan EK, Cyrlin MN (1999) The advanced glaucoma intervention study (AGIS). Encapsulated bleb after initial trabeculectomy. Am J Ophthalmol 127:8–19
Wimmer I, Welge-Luessen U, Picht G, Grehn F (2003) Influence of argon laser trabeculoplasty on transforming growth factor-beta 2 concentration and bleb scarring following trabeculectomy. Graefes Arch Clin Exp Ophthalmol 241:631–636
Latina MA, Sibyan SA, Shin DH, Noecker RJ, Marcellino G (1998) Q switched 532- nm Nd: YAG laser trabeculoplasty (selective laser trabeculoplasty): a multicenter, pilot, clinical study. Ophthalmology 105:2082–2088
Kramer TR, Noecker RJ (2001) Comparison of the morphologic changes after selective laser trabeculoplasty in human eye bank eyes. Ophthalmology 108:773–779
Izzotti A, Longobardi M, Cartiglia C, Rathschuler F, Sacca SC (2011) Trabecular meshwork gene expression after selective laser trabeculoplasty. PLoS ONE 6:e20110
Alvarado JA, Iguchi R, Martinez J, Trivedi S, Shifera AS (2010) Similar effects of selective laser trabeculoplasty and prostaglandin analogs on the permeability of cultured Schlemm canal cells. Am J Ophthalmol 150:254–264
Damji KF, Bovell AM, Hodge WG, Rock W, Shah K, Buhrmann R, Pan YI (2006) Selective laser trabeculoplasty versus argon laser trabeculoplasty: results from a 1-year randomized clinical trial. Br J Ophthalmol 90:1490–1494
Liu Y, Birt CM (2012) Argon versus selective laser trabeculoplasty in younger patients: 2-year results. J Glaucoma 21:112–115
Wong MO, Lee JW, Choy BN, Chan JC, Lai JS (2015) Systematic review and meta-analysis on the efficacy of selective laser trabeculoplasty in open-angle glaucoma. Surv Ophthalmol 60:36
Birt CM (2007) Selective laser trabeculoplasty retreatment after prior argon laser trabeculoplasty: 1-year result. Can J Ophthalmol 42:715–719
Russo V, Barone A, Cosma A, Stella A, Delle Noci N (2009) Selective laser trabeculoplasty versus argon laser trabeculoplasty in patients with uncontrolled open-angle glaucoma. Eur J Ophthalmol 19:429–434
Kim DY, Singh A (2008) Severe iritis and choroidal effusion following selective laser trabeculoplasty. Ophthalmic Surg Lasers Imaging 39:409–411
Lee JW, Chan JC, Chang RT, Singh K, Liu CC, Gangwani R, Wong MO, Lai JS (2014) Corneal changes after a single session of selective trabeculoplasty for open-angle glaucoma. Eye 28:47–52
Ha JH, Bowling B, Chen SD (2014) Cystoid macular oedema following selective laser trabeculoplasty in a diabetic patient. Clin Exp Ophthalmol 42:200–201
Law SK, Nguyen AM, Coleman AL, Capriolo J (2007) Severe loss of central vision in patients with advanced glaucoma undergoing trabeculectomy. Arch Ophthalmol 125:1044–1050
Francis BA, Signh K, Lin SC, Hodapp E, Jampell HD, Samples JR, Smith SD (2011) Novel glaucoma procedures: a report by the American Academy of Ophthalmology. Ophthalmology 118:1466–1480
Brusini P, Filacorda S (2006) Enhanced glaucoma staging system (GSS 2) for classifying functional damage in glaucoma. J Glaucoma 15:40–46
Katz LJ, Steinmann WC, Kabir A, Molineaux J, Wizov SS, Marcellino G (2012) Selective laser trabeculoplasty versus medical therapy as initial treatment of glaucoma: a prospective, randomized trial. J Glaucoma 21:460–468
Martow E, Hutnik CM, Mao A (2011) SLT and adjunctive medical therapy: a prediction rule analysis. J Glaucoma 20:266–270
Ayala M, Chen E (2011) Predictive factors of success in selective laser trabeculoplasty (SLT) treatment. Clin Ophthalmol 5:573–576
Bruen R, Lesk MR, Harasymowycz P (2012) Baseline factors predictive of SLT response: a prospective study. J Ophthalmol 2012:642869. doi:10.1155/2012/642869
Shazly TA, Latina MA, Dagianis JJ, Chitturi S (2012) Effect of central corneal thickness on the long-term outcome of selective laser trabeculoplasty as primary treatment for ocular hypertension and primary open-angle glaucoma. Cornea 31:883–886. doi:10.1097/ICO.0b013e318243f684
Lindegger DJ, Jaggi GP, Bauer G, Zweifel S, Töteberg-Harms M, Hirn C, Zehnder S, Funk J (2014) Long-term efficacy of selective laser trabeculoplasty in pseudophakic patients—a “real-life” analysis. Klin Monatsbl Augenheilkd 231:357–362
Tzimis V, Tze L, Ganesh J, Muhsen S, Kiss A, Kranemann C, Birt CM (2011) Laser trabeculoplasty: an investigation into factors that might influence outcomes. Can J Ophthalmol 46:305–309. doi:10.1016/j.jcjo.2011.06.005
Wasyluk JT, Piekarniak-Woźniak A, Grabska-Liberek I (2014) The hypotensive effect of selective laser trabeculoplasty depending on iridocorneal angle pigmentation in primary open angle glaucoma patients. Arch Med Sci 10:306–308. doi:10.5114/aoms.2014.42583
de Rolim Moura C, Paranhos A Jr, Wormald R (2007) Laser trabeculoplasty for open angle glaucoma. Cochrane Database Syst Rev 17:CD003919
Tham YC, Li X, Wong TY, Quigley HA, Aung T, Cheng CY (2014) Global prevalence of glaucoma and projections of glaucoma burden through 2040: a systematic review and meta-analysis. Ophthalmology. doi:10.1016/j.ophtha.2014.05.013
The AGIS Investigators (2000) The advanced glaucoma intervention study (AGIS): 7. The relationship between control of intraocular pressure and visual field deterioration. Am J Ophthalmol 130:429–440
Jampel HD, Solus JF, Tracey PA, Gilbert DL, Loyd TL, Jefferys JL, Quigley HA (2012) Outcomes and bleb-related complications of trabeculectomy. Ophtalmology 119:712–722
Bull H, von Wolff K, Körber N, Tetz M (2011) Three-year canaloplasty outcomes for the treatment of open-angle glaucoma: European study results. Graefes Arch Clin Exp Ophthalmol 249:1537–1545
Conflict of interest
The authors have declare no financial or conflicting interest.
Ethical standards
This retrospective study adhered to the tenets of the Declaration of Helsinki.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Schlote, T., Kynigopoulos, M. Selective laser trabeculoplasty (SLT): 1-year results in early and advanced open angle glaucoma. Int Ophthalmol 36, 55–61 (2016). https://doi.org/10.1007/s10792-015-0079-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10792-015-0079-1